The process typically involves the functionalization of nanoparticles with ligands that bind to specific receptors on the target cells. These ligands can be antibodies, peptides, aptamers, or small molecules. Once administered, these functionalized nanoparticles circulate through the body and accumulate at the target site by recognizing and binding to their specific markers.
